Takeda Goes Global With $13.7B Nycomed Deal
Takeda Pharmaceutical Co. Ltd. pushed into Europe on Thursday with the purchase of Swiss drugmaker Nycomed A/S for $13.7 billion in cash, giving the Japanese buyer access to Nycomed's $4 billion...To view the full article, register now.
Already a subscriber? Click here to view full article